Report initial mobilization, collection and engraftment data from the Stanford multiple myeloma trial
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 3 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- 4 Jun 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initial mobilization, collection and engraftment data from this trial are expected in mid-2021.”
What we found
Evidence strength A What the grades mean
Preliminary mobilization and collection data from the multiple myeloma trial were presented at ASCO in June 2021, before the mid-2021 deadline, with engraftment data reported in the same update.
-
A Magenta Therapeutics, Inc. 8-K filed 2021-08-05
“Preliminary trial data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, held June 4-8, 2021, showed that all patients (15/15) treated as of the data cut-off date with MGTA-145 and plerixafor met the primary endpoint” ✓ confirmed on the page
-
A Magenta Therapeutics, Inc. 8-K filed 2021-08-05
“As of the cut-off date, all patients (12/12) transplanted with MGTA-145 and plerixafor successfully engrafted” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Initial data from Stanford MGTA-145 multiple myeloma trial
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Magenta Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-DNTH-025052 · Corrections policy